Purchase Order 75N91018P00313

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $14,200 on May 24, 2019, with completion by August 1, 2019. The order is firm fixed price with no set-aside designation. Metabolon will deliver a relative concentration profile of small-molecule entities (endogenous compounds, xenobiotics, and metabolites) extracted from 40 cell pellets and detected via the HD4 global metabolomics platform, provided as an Excel file. The awardee will supply an outline of analytical...

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $16,000 on June 25, 2018, with final completion on June 24, 2019. The order is firm fixed price with no set-aside. Work is performed in Morrisville, North Carolina. Metabolon, a self-certified small disadvantaged business, provides metabolomics analysis services, including metabolite identification and quantification using ultra-high performance liquid chromatography and tandem mass spectrometry across biological...

The National Cancer Institute awarded a $16,000 purchase order to Metabolon, Inc. for custom metabolomics services on July 25, 2017, with completion on July 25, 2018. Work is performed in Durham, North Carolina. The order is firm fixed price with no set-aside designation. Metabolon is a self-certified small disadvantaged business specializing in metabolomic profiling and analysis using advanced chromatography and mass spectrometry techniques across biological sample types including plasma,...

The National Cancer Institute awarded a $12,000 firm fixed-price purchase order to Metabolon, Inc. on June 8, 2018, with final completion on June 7, 2019. Performance is at Metabolon's facility in Morrisville, North Carolina. The order procures metabolomic analysis services, including identification and quantification of metabolites from biological samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.

The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $19,200.00 on August 1, 2018, with final completion on August 18, 2018. No set-aside was used. Work is performed in Morrisville, North Carolina. The order covers metabolomic analysis services, including identification and quantification of metabolites from biological samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.

The National Cancer Institute awarded a $16,200 purchase order to Metabolon, Inc. for lab and testing services, effective November 26, 2019 with completion by January 31, 2020. Work is performed in Morrisville, North Carolina. No set-aside category applies. Metabolon, a self-certified small disadvantaged business, provides metabolomics services including metabolite identification and quantification using ultra-high performance liquid chromatography and tandem mass spectrometry for biological...

<p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $14,400.00 on September 15, 2017. No set-aside was used. The order is firm fixed price and runs through November 1, 2017. Work is performed in Morrisville, North Carolina. Metabolon is a self-certified small disadvantaged business providing metabolomics services, including metabolomic profiling of biological samples using advanced analytical techniques to support federal research initiatives.</p>

The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a firm fixed price purchase order valued at forty-seven thousand two hundred forty-two dollars and six cents ($47,242.06) to Metabolon, Inc. to measure metabolomic and lipidomic concentrations on fifty-eight incident pancreatic cancer cases and fifty-eight controls, along with six blinded replicate quality control samples, totaling one hundred twenty-two...

<p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $146,900.04 to measure metabolomics markers related to pancreatic cancer in human serum samples, with an award date of July 5, 2015 and completion date of January 31, 2017. Work is performed in Durham, North Carolina. The purchase order represents a de-obligation of funds from an expiring FY2015 line and carries firm fixed-price terms with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $18,460.00 on June 13, 2019, with final completion on July 13, 2019. The order procures a quality-controlled metabolite data set in Excel format listing every structurally named metabolite identified and relative abundance for 52 human breast tissues. Work is performed in Bethesda, Maryland. Firm fixed price, no set-aside used.</p>